Last10K.com

Aeterna Zentaris Inc. (AEZS) SEC Filing 6-K Foreign Issuer Report for the period ending Wednesday, June 14, 2023

Aeterna Zentaris Inc.

HISTORY TOOLS
CIK: 1113423 Ticker: AEZS

View differences made from one to another to evaluate Aeterna Zentaris Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 6-K Foreign Issuer Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Aeterna Zentaris Inc..

Continue

Assess how Aeterna Zentaris Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Aeterna Zentaris Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2023 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Material Contracts, Statements, Certifications & more

Aeterna Zentaris Inc. provided additional information to their SEC Filing as exhibits

Exhibit 99.1: Additional Exhibits
Ticker: AEZS
CIK: 1113423
Form Type: 6-K Foreign Issuer Report
Accession Number: 0001493152-23-021253
Submitted to the SEC: Wed Jun 14 2023 4:42:58 PM EST
Accepted by the SEC: Wed Jun 14 2023
Period: Wednesday, June 14, 2023
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/aezs/0001493152-23-021253.htm